Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 171,730 Raw stories ingested 22,804 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 47s ago
  • FMP Forex News Fetch every 5 min 47s ago
  • CoinGecko News Fetch every 5 min 2m ago
  • FIO Stock News Fetch every 10 min 1m ago
  • Patria Stock News Fetch every 10 min 1m ago
  • Editorial rewrite Rewrite every minute 47s ago
  • Asset sync Assets every 1 hour 47s ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Details Date Content Source
2026-06-12 17:49 3mo ago
2026-06-10 06:52 3mo ago
Celsius: Oversold While Nearing Technical Support - Rich Upsides Trigger Buy Rating
CELH Celsius Holdings
FMP Stock News
Original source text
Celsius's acquisition of Alani Nu expanded its Energy MULO+W/C Dollar Share to 20.9% (+10.1% YoY), capturing share from Red Bull/Monster while supporting the former's renewed growth prospects. Their innovation pipeline for the legacy CELSIUS brand and the expanded international footprint are also driving incremental market share gains/growth opportunities. Thanks to the -50.6% stock correction, CELH trades at a discounted P/E of 17.83x and a PEG of 1.02x, while offering an excellent upside potential to my bull-case LTPT of $47.70.
2026-06-12 17:49 3mo ago
2026-06-10 10:01 3mo ago
Investors Heavily Search Celsius Holdings Inc. (CELH): Here is What You Need to Know
CELH Celsius Holdings
FMP Stock News
Original source text
Zacks.com users have recently been watching Celsius (CELH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2026-06-12 17:49 3mo ago
2026-06-10 10:16 3mo ago
Celsius Holdings' Portfolio Reaches 20.9% Share: More Gains Ahead?
CELH Celsius Holdings
FMP Stock News
Original source text
CELH hits a 20.9% U.S. energy-drink dollar share in Q1 2026 as Alani Nu surges. Retail resets are likely to add more shelf space.
2026-06-12 17:49 3mo ago
2026-06-11 01:11 3mo ago
Celsius Holdings: Strong Growth, But The Moat Has Not Yet Been Proven
CELH Celsius Holdings
FMP Stock News
Original source text
Celsius Holdings delivered 138% revenue growth in Q1 2026, driven primarily by Alani Nu and Rockstar acquisitions. I see CELH as a buy at $28, with a reasonable valuation and strong upside if Alani Nu sustains momentum and margins recover. Gross margin declined from 52.3% to 48.3%, highlighting the integration challenge and need for margin improvement post-acquisitions.
2026-06-12 17:49 3mo ago
2026-06-11 10:31 3mo ago
Brokers Suggest Investing in Celsius (CELH): Read This Before Placing a Bet
CELH Celsius Holdings
FMP Stock News
Original source text
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
2026-06-12 17:49 3mo ago
2026-06-11 19:05 3mo ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celsius Holdings, Inc. - CELH
CELH Celsius Holdings
FMP Stock News
Original source text
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
2026-06-12 17:49 3mo ago
2026-05-20 08:00 3mo ago
Jamf Names Beth Tschida as Chief Executive Officer
JAMF Jamf Holding
FMP Stock News
Original source text
MINNEAPOLIS--(BUSINESS WIRE)--Jamf, the standard in managing and securing Apple at work, today announced the appointment of Beth Tschida as Chief Executive Officer, effective immediately. Tschida, who has served as interim CEO since March 2026 and previously as Jamf's Chief Technology Officer, brings to the role a track record of leading innovation across cloud, security and the Jamf platform. Tschida succeeds John Strosahl, who led the company through its transition to private ownership follow.
2026-06-12 17:49 3mo ago
2026-05-06 07:00 4mo ago
CDW Reports First Quarter 2026 Earnings
CDW CDW
FMP Stock News
Original source text
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW): (Dollars in millions, except per share amounts) Three Months Ended March 31,   2026     2025   Percent Change Net sales $ 5,679.8   $ 5,199.1   9.2 % Gross profit $ 1,190.0   $ 1,122.3   6.0   Gross profit margin   21.0 %   21.6 %   Operating income $ 376.0   $ 361.4   4.0   Operating income margin   6.6 %   7.0 %   Non-GAAP operating income1 $ 451.9   $ 444.0   1.8   Non-GAAP operating income margin1   8.0 %   8.5 %   Net inco.
2026-06-12 17:49 3mo ago
2026-05-06 07:05 4mo ago
CDW Declares Quarterly Cash Dividend of $0.630 Per Share
CDW CDW
FMP Stock News
Original source text
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW) announced today that its Board of Directors declared a quarterly cash dividend of $0.630 per common share to be paid on June 10, 2026 to all stockholders of record as of the close of business on May 25, 2026. "Dividends represent an important component of our capital allocation priorities, along with share repurchases, strategic M&A, and managing our capital structure," said Albert J. Miralles, chief financial officer, CDW.
2026-06-12 17:49 3mo ago
2026-05-06 08:20 4mo ago
CDW posts first-quarter revenue beat on strong IT demand amid AI, cloud boom
CDW CDW
FMP Stock News
Original source text
CDW topped Wall Street expectations for first-quarter revenue on Wednesday, helped by ​resilient demand for its information technology solutions ‌as businesses ramp up spending on artificial intelligence and cloud technology.
2026-06-12 17:49 3mo ago
2026-05-06 09:25 4mo ago
CDW (CDW) Meets Q1 Earnings Estimates
CDW CDW
FMP Stock News
Original source text
CDW (CDW) came out with quarterly earnings of $2.28 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $2.15 per share a year ago.
2026-06-12 17:49 3mo ago
2026-05-06 11:55 4mo ago
CDW Q1 Earnings Meet, Revenues Rise Y/Y on Infrastructure & AI Adoption
CDW CDW
FMP Stock News
Original source text
CDW posts solid Q1 2026 with rising sales and steady EPS, as strong demand across segments and AI investments shape its 2026 outlook.
2026-06-12 17:49 3mo ago
2026-05-06 12:31 4mo ago
CDW Corporation (CDW) Q1 2026 Earnings Call Transcript
CDW CDW
FMP Stock News
Original source text
CDW Corporation (CDW) Q1 2026 Earnings Call Transcript
2026-06-12 17:49 3mo ago
2026-05-07 08:05 4mo ago
CDW Corporation: A 20% Decline Could Be A Gift For Investors (Upgrade)
CDW CDW
FMP Stock News
Original source text
CDW Corporation (CDW) shares have declined nearly 40% since last July, underperforming the S&P 500 by a wide margin. Q1 2026 saw revenue up 9% YoY to $5.68B, but gross margins contracted, particularly in the Government segment, pressuring the stock post-earnings. Management maintained cautious 2026 guidance due to supply chain variability and memory constraints, despite broad-based segment growth.
2026-06-12 17:49 3mo ago
2026-05-07 10:36 4mo ago
CDW (CDW) Loses 14.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
CDW CDW
FMP Stock News
Original source text
CDW (CDW) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
2026-06-12 17:49 3mo ago
2026-05-07 12:30 4mo ago
CDW (CDW) Reports Q1 Earnings: What Key Metrics Have to Say
CDW CDW
FMP Stock News
Original source text
The headline numbers for CDW (CDW) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2026-06-12 17:49 3mo ago
2026-05-11 10:40 4mo ago
Why CDW (CDW) is a Top Value Stock for the Long-Term
CDW CDW
FMP Stock News
Original source text
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
2026-06-12 17:49 3mo ago
2026-05-13 08:30 3mo ago
CDW Authorizes $1 Billion Share Repurchase Program Increase
CDW CDW
FMP Stock News
Original source text
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW) announced today that its Board of Directors has authorized a $1 billion increase to the Company's share repurchase program. "Share repurchases represent an important component of our capital allocation priorities, along with dividends, strategic M&A, and managing our capital structure," said Albert J. Miralles, chief financial officer, CDW. "Since our IPO in June 2013 we have returned approximately $8.4 billion to stockholde.
2026-06-12 17:49 3mo ago
2026-05-14 10:41 3mo ago
Are Investors Undervaluing CDW (CDW) Right Now?
CDW CDW
FMP Stock News
Original source text
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
2026-06-12 17:49 3mo ago
2026-05-19 13:50 3mo ago
CDW Corporation (CDW) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
CDW CDW
FMP Stock News
Original source text
CDW Corporation (CDW) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
2026-06-12 17:49 3mo ago
2026-05-20 12:12 3mo ago
CDW Corporation: More Is Needed Before The Stock Can See An Upward Re-Rating
CDW CDW
FMP Stock News
Original source text
CDW Corporation (CDW) remains a hold as revenue growth improved in Q1 2026, but quality of growth and margin trends remain concerning. Hardware demand, especially from AI inferencing in Financial Services, drove top-line gains, while netted-down revenue was flat and gross margin fell 60 bps. Corporate segment showed signs of recovery, but pull-forward sales and weak higher-margin mix cloud the sustainability of growth.
2026-06-12 17:49 3mo ago
2026-05-20 19:05 3mo ago
CDW Touts AI Factory Demand, Recurring Revenue Push at JPMorgan Conference
CDW CDW
FMP Stock News
Original source text
CDW NASDAQ: CDW executives said customers are moving beyond artificial intelligence experimentation and are increasingly asking for help deploying AI “safely, economically, and at scale,” during a JPMorgan fireside chat featuring Chair and CEO Christine Leahy and CFO Albert Miralles.
2026-06-12 17:49 3mo ago
2026-05-27 10:40 3mo ago
Here's Why CDW (CDW) is a Strong Value Stock
CDW CDW
FMP Stock News
Original source text
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2026-06-12 17:49 3mo ago
2026-06-01 13:02 3mo ago
CDW (CDW) Upgraded to Buy: Here's Why
CDW CDW
FMP Stock News
Original source text
CDW (CDW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2026-06-12 17:49 3mo ago
2026-06-03 10:51 3mo ago
Why CDW (CDW) is a Top Momentum Stock for the Long-Term
CDW CDW
FMP Stock News
Original source text
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2026-06-12 17:49 3mo ago
2026-06-05 12:36 3mo ago
CDW (CDW) Up 26.5% Since Last Earnings Report: Can It Continue?
CDW CDW
FMP Stock News
Original source text
CDW (CDW) reported earnings 30 days ago. What's next for the stock?
2026-06-12 17:49 3mo ago
2026-03-12 16:40 6mo ago
Auto Marketplace Stock Down 65% in a Year as One Fund Liquidates $12 Million Stake
ACVA ACV Auctions
FMP Stock News
Original source text
Engle Capital sold 1,213,329 shares of ACV Auctions in the fourth quarter. The quarter-end position value decreased by $12.02 million as a result.
2026-06-12 17:49 3mo ago
2026-03-12 20:35 6mo ago
Royce Smaller-Companies Growth Fund FY 2025: What Worked
ACVA ACV Auctions
FMP Stock News
Original source text
Nine of the portfolio's 10 equity sectors made a positive impact on performance, with Health Care, Industrials, and Materials making the largest positive contributions. Palvella's shares appreciated significantly in 2025 as investors grew more confident in the company's pipeline following a grant from the FDA, patent wins, and a positive Phase II readout. Impinj is a long time holding in the portfolio with a very large total addressable market expansion opportunity, a strong patent portfolio, and an increasingly diversified customer base.
2026-06-12 17:49 3mo ago
2026-03-15 03:52 5mo ago
ACV Auctions Inc. $ACVA Stock Position Lifted by ArrowMark Colorado Holdings LLC
ACVA ACV Auctions
FMP Stock News
Original source text
ArrowMark Colorado Holdings LLC lifted its position in ACV Auctions Inc. (NYSE: ACVA) by 30.4% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,337,335 shares of the company's stock after acquiring an additional 1,475,932 shares during the quarter.
2026-06-12 17:49 3mo ago
2026-03-19 12:38 5mo ago
ACV Expands MAX Suite, Delivers AI-Powered, Profit-Focused Inventory Guidance with New ACV MAX Recommendations Feature
ACVA ACV Auctions
FMP Stock News
Original source text
BUFFALO, N.Y.--(BUSINESS WIRE)--ACV (NYSE: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, today announced the launch of ACV MAX RecommendationsTM, a new AI-powered feature within the ACV MAX suite designed to deliver profit-focused guidance on every new and used vehicle. Built on ACV's industry-leading data and powered by insight-driven AI, ACV MAX Recommendations provides real-time, VIN-specific pricing and inventory guidance fo.
2026-06-12 17:49 3mo ago
2026-04-22 16:05 4mo ago
ACV to Report First Quarter 2026 Financial Results on May 6, 2026
ACVA ACV Auctions
FMP Stock News
Original source text
BUFFALO, N.Y.--(BUSINESS WIRE)--ACV (NYSE: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, announced today that the Company will report first quarter 2026 financial results after market close and host a conference call at 5:00 p.m. ET on Wednesday, May 6, 2026.

Investors and analysts interested in participating in the call are invited to dial 877-704-4453 (international callers please dial 1-201-389-0920) approximately 10 minutes prior to the start of the call.

A live webcast of the call will be available on the Company’s investor relations website at https://investors.acvauto.com/, and an archived replay will be available following the live event.

About ACV
ACV is on a mission to transform the automotive industry by building the most trusted and efficient digital marketplaces and data solutions for sourcing, selling and managing used vehicles with transparency and comprehensive insights that were once unimaginable.

ACV offerings include ACV Auctions, ACV Transportation, ACV Capital, MAX Digital, True360, and ClearCar. For more information about ACV, visit www.acvauto.com.

Trademark reference: ACV, the ACV logo, and ClearCar are registered trademarks or trademarks of ACV Auctions, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.
2026-06-12 17:49 3mo ago
2026-04-29 11:01 4mo ago
ACV Auctions Inc. (ACVA) Expected to Beat Earnings Estimates: Should You Buy?
ACVA ACV Auctions
FMP Stock News
Original source text
The market expects ACV Auctions Inc. (ACVA - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 6. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -25%.

Revenues are expected to be $201.43 million, up 10.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 5.26% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for ACV Auctions?For ACV Auctions, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +15.39%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination indicates that ACV Auctions will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that ACV Auctions would post a loss of$0.01 per share when it actually produced break-even earnings, delivering a surprise of +100.00%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

ACV Auctions appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-06-12 17:49 3mo ago
2026-05-06 16:05 4mo ago
ACV Announces First Quarter 2026 Results
ACVA ACV Auctions
FMP Stock News
Original source text
BUFFALO, N.Y.--(BUSINESS WIRE)--ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, today reported results for its first quarter ended March 31, 2026.

“ACV delivered solid financial results in Q1-26, reporting record revenue and Adjusted EBITDA above the high-end of guidance. Results were driven by continued market share gains in dealer wholesale and strong adoption of our Marketplace Services,” said George Chamoun, CEO of ACV. “Our suite of AI-powered dealer solutions gained further market traction, highlighted by the successful launch of VIPER with select dealer partners, which creates a powerful new driver of wallet share expansion and unit growth. We also continued to execute on our commercial wholesale strategy having recently engaged with over a dozen commercial accounts across major captives, banks, fleet companies, and auto finance providers. We believe that along with delivering market share gains in dealer wholesale, ACV is well positioned to expand our TAM and drive sustainable long-term revenue growth,” concluded Chamoun.

“ACV's first quarter results reinforce our commitment to deliver profitable growth while also increasing investments to drive dealer wholesale market share, and to support our exciting new growth initiatives,” said Bill Zerella, CFO of ACV. “Our team delivered these results while facing challenging retail and wholesale trends in the quarter. And, despite the uncertain macroeconomic backdrop we are reaffirming our 2026 revenue and Adjusted EBITDA guidance. We are also pleased to announce that ACV's Board of Directors has authorized a share repurchase program of up to $100 million and intends, in the coming days, to enter into an accelerated share repurchase program under this authorization to repurchase an aggregate of $50 million of its common stock,” concluded Zerella.

First Quarter 2026 Highlights

Revenue of $204 million, an increase of 12% year over year Marketplace and Service Revenue of $182 million, an increase of 10% year over year Marketplace GMV of $2.7 billion, an increase of 5% year over year Marketplace Units of 213,492, an increase of 3% year over year GAAP net income (loss) of ($11) million, compared to GAAP net income (loss) of ($15) million in the first quarter of 2025 Non-GAAP net income of $7 million, compared to non-GAAP net income of $7 million in the first quarter of 2025 Adjusted EBITDA of $17 million, compared to Adjusted EBITDA of $14 million in the first quarter of 2025 Second Quarter and Full-Year 2026 Guidance

Based on information as of today, ACV is providing the following guidance:

Second Quarter of 2026: Total revenue of $213 million to $217 million, an increase of 10% to 12% year over year GAAP net income (loss) of ($14) million to ($12) million Non-GAAP net income of $8 million to $10 million Adjusted EBITDA of $18 million to $20 million Full-Year 2026: Total revenue of $845 million to $855 million, an increase of 11% to 13% year over year GAAP net income (loss) of ($51) million to ($47) million Non-GAAP net income of $33 million to $37 million Adjusted EBITDA of $73 million to $77 million Our financial guidance includes the following assumptions:

The dealer wholesale market is expected to decline in the mid-single digits year over year in 2026, a higher decline than previously expected. Conversion rates and wholesale price depreciation expected to follow normal seasonal patterns. Non-GAAP Operating Expense (excluding Cost of Revenue) is expected to increase approximately 8% year-over-year. Second quarter non-GAAP net income guidance excludes approximately $18 million of stock-based compensation expense and approximately $3 million of intangible amortization. Full-year non-GAAP net income guidance excludes approximately $66 million of stock-based compensation expense and $11 million of intangible amortization. ACV’s First Quarter Results Conference Call

ACV will host a conference call and live webcast today, May 6, 2026, at 5:00 p.m. ET to discuss the financial results. To access the live conference call participants are invited to dial 877-704-4453 (international callers please dial 1-201-389-0920) approximately 10 minutes prior to the start of the call. A live webcast and replay of the call will be available on the Company’s investor relations website at https://investors.acvauto.com/. Participants are encouraged to join the webcast unless asking a question.

About ACV Auctions

ACV is on a mission to transform the automotive industry by building the most trusted and efficient digital marketplace and data solutions for sourcing, selling and managing used vehicles with transparency and comprehensive insights that were once unimaginable. ACV offerings include ACV Auctions, ACV Transportation, ACV Capital, ACV MAX, True360, and ClearCar.

For more information about ACV, visit www.acvauto.com.

Information About Non-GAAP Financial Measures

ACV provides supplemental non-GAAP financial measures to its financial results. We use these non-GAAP financial measures, and we believe that they assist our investors to make period-to-period comparisons of our operating performance because they provide a view of our operating results without items that are not, in our view, indicative of our operating results. These non-GAAP financial measures should not be construed as an alternative to GAAP results as the items excluded from the non-GAAP financial measures often have a material impact on our operating results, certain of those items are recurring, and others often recur. Management uses, and investors should consider, our non-GAAP financial measures only in conjunction with our GAAP results.

Non-GAAP Financial Measures

Adjusted EBITDA is a financial measure that is not presented in accordance with GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation and evaluating our operating performance, as well as for internal planning and forecasting purposes.

We define Adjusted EBITDA as net loss, adjusted to exclude: depreciation and amortization; stock-based compensation expense; interest (income) expense; provision for income taxes; and other one-time non-recurring items, when applicable, such as acquisition-related and restructuring expenses.

Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of these limitations include that (1) it does not properly reflect capital commitments to be paid in the future; (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures; (3) it does not consider the impact of stock-based compensation expense, (4) it does not reflect other non-operating income and expenses, including interest income and expense, (5) it does not consider the impact of any contingent consideration liability valuation adjustments, (6) it does not reflect tax payments that may represent a reduction in cash available to us, and (7) it does not reflect other one-time, non-recurring items, when applicable, such as acquisition-related and restructuring expenses. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net loss and other results stated in accordance with GAAP.

Non-GAAP net income (loss), a financial measure that is not presented in accordance with GAAP, provides investors with additional useful information to measure operating performance and current and future liquidity when taken together with our financial results presented in accordance with GAAP. By providing this information, we believe management and the users of the financial statements are better able to understand the financial results of what we consider to be our continuing operations.

We define non-GAAP net income (loss) as net income (loss), adjusted to exclude: stock-based compensation expense, amortization of acquired intangible assets, and other one-time, non-recurring items, when applicable, such as acquisition-related and restructuring expenses.

In the calculation of non-GAAP net income (loss), we exclude stock-based compensation expense because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact our non-cash expense. We believe that providing non-GAAP financial measures that exclude stock-based compensation expense allows for more meaningful comparisons between our operating results from period to period.

We exclude amortization of acquired intangible assets from the calculation of non-GAAP net income (loss). We believe that excluding the impact of amortization of acquired intangible assets allows for more meaningful comparisons between operating results from period to period as the underlying intangible assets are valued at the time of acquisition and are amortized over several years after the acquisition.

We exclude contingent consideration liability valuation adjustments associated with the purchase consideration of transactions accounted for as business combinations. We also exclude certain other one-time, non-recurring items, when applicable, such as acquisition-related and restructuring expenses, because we do not consider such amounts to be part of our ongoing operations nor are they comparable to prior period nor predictive of future results.

Non-GAAP net income (loss) is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of these limitations include that: (1) it does not consider the impact of stock-based compensation expense; (2) although amortization is a non-cash charge, the underlying assets may need to be replaced and non-GAAP net income (loss) does not reflect these capital expenditures; (3) it does not consider the impact of any contingent consideration liability valuation adjustments; and (4) they do not consider the impact of other one-time charges, such as acquisition-related and restructuring expenses, which could be material to the results of our operations. In addition, our use of non-GAAP net income (loss) may not be comparable to similarly titled measures of other companies because they may not calculate non-GAAP net income (loss) in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider non-GAAP net income (loss) alongside other financial measures, including our net loss, and other results stated in accordance with GAAP.

Information About Operating and Financial Metrics

We regularly monitor the following operating and financial metrics in order to measure our current performance and estimate our future performance. Our key operating and financial metrics may be calculated in a manner different than similar business metrics used by other companies.

Operating and Financial Metrics

Marketplace GMV - Marketplace GMV is primarily driven by the volume and dollar value of Marketplace Unit transactions. We believe that Marketplace GMV acts as an indicator of our success, signaling satisfaction of dealers and buyers, and the health, scale, and growth of our business. We define Marketplace GMV as the total dollar value of vehicles transacted within the applicable period, excluding any auction and ancillary fees.

Marketplace Units - Marketplace Units is a key indicator of our potential for growth in Marketplace GMV and revenue. It demonstrates the overall engagement of our customers and our market share of wholesale transactions in the United States. We define Marketplace Units as the number of vehicles transacted within the applicable period. Marketplace Units transacted includes any vehicle that successfully reaches sold status, even if the auction is subsequently unwound, meaning the buyer or seller does not complete the transaction. These instances have been immaterial to date. Marketplace Units excludes vehicles that were inspected by ACV, but not sold. Marketplace Units have generally increased over time as we have expanded our territory coverage, added new dealer partners and increased our share of wholesale transactions from existing customers.

Forward-Looking Statements

This presentation contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements concerning our financial guidance for the second quarter of 2026 and the full year of 2026. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will” or “would” or the negative of these words or other similar terms or expressions. You should not rely on forward-looking statements as predictions of future events.

The forward-looking statements contained in this presentation are based on ACV’s current assumptions, expectations and beliefs and are subject to substantial risks, uncertainties and changes in circumstances that may cause ACV’s actual results, performance or achievements to differ materially from those expressed or implied in any forward-looking statement. These risks and uncertainties include, but are not limited to: (1) our history of operating losses; (2) our limited operating history; (3) our ability to effectively manage our growth; (4) our ability to grow the number of participants on our marketplace platform; (5) general market, political, economic, and business conditions; (6) our ability to acquire new customers and successfully retain existing customers; (7) our ability to effectively develop and expand our sales and marketing capabilities; (8) our ability to successfully introduce new products and services; (9) breaches in our security measures, unauthorized access to our marketplace platform, our data, or our customers’ or other users’ personal data; (10) risk of interruptions or performance problems associated with our products and platform capabilities; (11) our ability to adapt and respond to rapidly changing technology or customer needs; (12) our ability to compete effectively with existing competitors and new market entrants; (13) our ability to comply or remain in compliance with laws and regulations that currently apply or become applicable to our business in the United States and other jurisdictions where we elect to do business; (14) the impact that economic conditions could have on our or our customers’ businesses, financial condition and results of operations; and (15) the impact of such economic conditions in the wholesale dealer market included in our guidance for the second quarter of 2026 and full year 2026, and the related impact on the performance of our marketplace and our operating expenses, stock-based compensation expense and intangible amortization. These and other risks and uncertainties are more fully described in our filings with the Securities and Exchange Commission (“SEC”), including in the section entitled “Risk Factors” in our Form 10-K for the year ended December 31, 2025, filed with the SEC on February 23, 2026. Additional information will be made available in other filings and reports that we may file from time to time with the SEC. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, we cannot guarantee future results, levels of activity, performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. The forward-looking statements made in this presentation relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this presentation to reflect events or circumstances after the date of this presentation or to reflect new information or the occurrence of unanticipated events, except as required by law.

ACV AUCTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except per share data)

  Three months ended March 31,

2026

2025

Revenue:

Marketplace and service revenue

$

182,210

$

165,937

Customer assurance revenue

21,982

16,760

Total revenue

204,192

182,697

Operating expenses:

Marketplace and service cost of revenue (excluding depreciation & amortization)

79,820

69,402

Customer assurance cost of revenue (excluding depreciation & amortization)

18,980

13,977

Operations and technology

46,470

44,190

Selling, general, and administrative

56,238

59,018

Depreciation and amortization

11,920

10,541

Total operating expenses

213,428

197,128

Loss from operations

(9,236

)

(14,431

)

Other (expense) income:

Interest income

1,694

1,889

Interest expense

(2,820

)

(1,910

)

Total other (expense) income

(1,126

)

(21

)

Loss before income taxes

(10,362

)

(14,452

)

Provision for income taxes

530

365

Net loss

$

(10,892

)

$

(14,817

)

Weighted-average shares - basic and diluted

173,356

168,347

Net loss per share - basic and diluted

$

(0.06

)

$

(0.09

)

  ACV AUCTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

  March 31,

2026

December 31,

2025

Assets

Current Assets:

Cash and cash equivalents

$

340,970

$

271,497

Trade receivables (net of allowance of $5,398 and $3,829)

268,867

197,225

Finance receivables (net of allowance of $22,256 and $29,026)

190,432

180,486

Other current assets

24,019

24,295

Total current assets

824,288

673,503

Property and equipment (net of accumulated depreciation of $7,304 and $6,589)

13,654

12,852

Goodwill

183,052

183,725

Acquired intangible assets (net of amortization of $42,642 and $40,202)

78,290

81,024

Capitalized software (net of amortization of $76,085 and $67,874)

84,840

81,964

Other assets

51,257

52,543

Total assets

$

1,235,381

$

1,085,611

Liabilities and Stockholders' Equity

Current Liabilities:

Accounts payable

$

526,634

$

390,830

Accrued payroll

10,732

9,308

Accrued other liabilities

22,988

20,711

Total current liabilities

560,354

420,849

Long-term debt

200,000

190,000

Other long-term liabilities

44,103

45,079

Total liabilities

804,457

655,928

Commitments and Contingencies

Stockholders' Equity:

Preferred Stock





Common Stock

174

173

Additional paid-in capital

1,009,840

996,628

Accumulated deficit

(579,348

)

(568,456

)

Accumulated other comprehensive income

258

1,338

Total stockholders' equity

430,924

429,683

Total liabilities and stockholders' equity

$

1,235,381

$

1,085,611

  ACV AUCTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(in thousands)

  Three months ended March 31,

2026

2025

Cash Flows from Operating Activities

Net loss

$

(10,892

)

$

(14,817

)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation and amortization

11,920

10,547

Stock-based compensation expense, net of amounts capitalized

13,464

16,574

Provision for bad debt

5,254

1,603

Other non-cash, net

821

704

Changes in operating assets and liabilities:

Trade receivables

(74,294

)

(75,714

)

Other operating assets

41

(2,616

)

Accounts payable

126,445

122,834

Other operating liabilities

3,751

7,509

Net cash provided by operating activities

76,510

66,624

Cash Flows from Investing Activities

Net increase in finance receivables

(3,363

)

(17,276

)

Purchases of property and equipment

(1,772

)

(1,346

)

Capitalization of software costs

(9,663

)

(8,731

)

Purchases of marketable securities



(10,153

)

Maturities and redemptions of marketable securities



6,638

Net cash used in investing activities

(14,798

)

(30,868

)

Cash Flows from Financing Activities

Proceeds from long term debt

85,000

100,000

Payments towards long term debt

(75,000

)

(56,500

)

Proceeds from exercise of stock options

690

382

Payment of RSU tax withholdings in exchange for common shares surrendered by RSU holders

(2,780

)

(11,808

)

Other financing activities



(42

)

Net cash provided by financing activities

7,910

32,032

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

(149

)

32

Net increase in cash, cash equivalents, and restricted cash

69,473

67,820

Cash, cash equivalents, and restricted cash, beginning of period

271,497

224,065

Cash, cash equivalents, and restricted cash, end of period

$

340,970

$

291,885

  The following table presents a reconciliation of non-GAAP net income to net loss, the most directly comparable financial measure stated in accordance with GAAP, for the periods presented (in thousands):

Three months ended March 31,

2026

2025

Net loss

$

(10,892

)

$

(14,817

)

Stock-based compensation

13,464

16,574

Amortization of acquired intangible assets

2,596

2,773

Amortization of capitalized stock based compensation

1,548

1,463

Acquisition-related costs



403

Litigation-related costs (1)



1,100

Other

610



Non-GAAP Net income

$

7,326

$

7,496

(1) Litigation-related costs are related to an anti-competition case which we do not consider to be representative of our underlying operating performance

The following table presents a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable financial measure stated in accordance with GAAP, for the periods presented (in thousands):

Three months ended March 31,

2026

2025

Adjusted EBITDA Reconciliation

Net loss

$

(10,892

)

$

(14,817

)

Depreciation and amortization

11,920

10,546

Stock-based compensation

13,464

16,574

Net interest expense

1,126

21

Provision for income taxes

530

365

Acquisition-related costs



403

Litigation-related costs (1)



1,100

Other

955

(284

)

Adjusted EBITDA

$

17,103

$

13,908

(1) Litigation-related costs are related to an anti-competition case which we do not consider to be representative of our underlying operating performance

The following table presents a reconciliation of non-GAAP net income (loss) to GAAP net loss, the most directly comparable financial measure stated in accordance with GAAP, for the periods presented (in millions):

Three months ended

June 30, 2026

Year ended

December 31, 2026

Non-GAAP net income (loss) to net income (loss) guidance Reconciliation

Net income (loss)

($14) - ($12)

($51) - ($47)

Non-GAAP Adjustments:

Stock-based compensation

$18

$66

Intangible amortization

$3

$11

Amortization of capitalized stock-based compensation

$2

$6

Other



$1

Non-GAAP net income (loss)

$8 - $10

$33 - $37
2026-06-12 17:49 3mo ago
2026-05-06 19:35 4mo ago
ACV Auctions Inc. (ACVA) Tops Q1 Earnings and Revenue Estimates
ACVA ACV Auctions
FMP Stock News
Original source text
ACV Auctions Inc. (ACVA - Free Report) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +92.31%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced break-even earnings, delivering a surprise of +100%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

ACV Auctions, which belongs to the Zacks Auction and Valuation Services industry, posted revenues of $204.19 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.37%. This compares to year-ago revenues of $182.7 million. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

ACV Auctions shares have lost about 32.7% since the beginning of the year versus the S&P 500's gain of 6%.

What's Next for ACV Auctions?While ACV Auctions has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for ACV Auctions was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.05 on $214.34 million in revenues for the coming quarter and $0.18 on $848.13 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Auction and Valuation Services is currently in the top 19% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Copart, Inc. (CPRT - Free Report) , has yet to report results for the quarter ended April 2026.

This company is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Copart, Inc.'s revenues are expected to be $1.23 billion, up 1.6% from the year-ago quarter.
2026-06-12 17:49 3mo ago
2026-05-07 04:41 4mo ago
ACV Auctions Inc. (ACVA) Q1 2026 Earnings Call Transcript
ACVA ACV Auctions
FMP Stock News
Original source text
ACV Auctions Inc. (ACVA) Q1 2026 Earnings Call Transcript
2026-06-12 17:49 3mo ago
2026-05-07 09:15 4mo ago
ACV Unveils All-in-One Inventory Intelligence Suite for Dealers
ACVA ACV Auctions
FMP Stock News
Original source text
BUFFALO, N.Y.--(BUSINESS WIRE)--ACV (NYSE: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, today announced enhancements to ACV MAX as a fully integrated inventory intelligence suite designed to give dealers a more powerful, data-driven way to source, price, manage, and sell vehicles more profitably and with confidence. As dealers face increasing margin pressure and market volatility, traditional inventory management tools are no l.
2026-06-12 17:49 3mo ago
2026-05-12 12:26 4mo ago
ACV Auctions: Turning Bullish After Q1 Beat And New Repurchase Program
ACVA ACV Auctions
FMP Stock News
Original source text
I'm upgrading ACV Auctions from 'Hold' to 'Buy, following my evaluation of its performance, prospects, and shareholder returns. ACVA turned around from losses in 4Q2025 to deliver a positive net profit of $7M for 1Q2026; that represented a 37% outperformance versus consensus. The company is forecasting a high-teens earnings growth in FY2026; management's confidence in this strong guidance is backed up by the significant buyback plans announced recently.
2026-06-12 17:49 3mo ago
2026-05-13 16:05 3mo ago
ACV to Participate in the 2026 J.P. Morgan Global Technology, Media and Communications Conference
ACVA ACV Auctions
FMP Stock News
Original source text
-

BUFFALO, N.Y.--(BUSINESS WIRE)--ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that members of its management team will present at the 2026 J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 20, 2026 at 9:20 a.m. ET.

A live webcast will be available on the Company’s investor relations website at https://investors.acvauto.com/, and an archived replay will be available following the event.

About ACV

ACV is on a mission to transform the automotive industry by building the most trusted and efficient digital marketplace and data solutions for sourcing, selling and managing used vehicles with transparency and comprehensive insights that were once unimaginable. ACV offerings include ACV Auctions, ACV Transportation, ACV Capital, ACV MAX, True360, and ClearCar.

For more information about ACV, visit www.acvauto.com.

More News From ACV

Back to Newsroom
2026-06-12 17:49 3mo ago
2026-05-20 12:30 3mo ago
ACV Auctions Inc. (ACVA) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
ACVA ACV Auctions
FMP Stock News
Original source text
ACV Auctions Inc. (ACVA) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
2026-06-12 17:49 3mo ago
2026-04-30 07:56 4mo ago
Cannabis ETFs: Regulatory Momentum Returns Focus
CURLF Curaleaf Holdings
FMP Stock News
Original source text
Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act.
2026-06-12 17:49 3mo ago
2026-04-30 16:02 4mo ago
Curaleaf Announces Date of Annual and Special Shareholders Meeting
CURLF Curaleaf Holdings
FMP Stock News
Original source text
STAMFORD, Conn., April 30, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announces that the Annual and Special Meeting of its shareholders (the "Meeting") will be held on Monday, June 22, 2026, at 9:00 a.m.
2026-06-12 17:49 3mo ago
2026-04-30 16:30 4mo ago
Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
CURLF Curaleaf Holdings
FMP Stock News
Original source text
STAMFORD, Conn., April 30, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, has completed the buyout of the remaining 45% stake not previously owned in Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis.
2026-06-12 17:49 3mo ago
2026-05-01 07:45 4mo ago
Curaleaf Announces Appointment of Torsten Greif to Board of Directors
CURLF Curaleaf Holdings
FMP Stock News
Original source text
STAMFORD, Conn., May 1, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the appointment of Torsten Greif to the Curaleaf Board of Directors.
2026-06-12 17:49 3mo ago
2026-05-05 16:01 4mo ago
Curaleaf Reports First Quarter 2026 Results: Robust Growth and Net Income
CURLF Curaleaf Holdings
FMP Stock News
Original source text
First quarter 2026 net revenue of $324 million

First quarter 2026 International revenue of $47 million 

First quarter 2026 gross profit margin of 49%

First quarter net income of $70 million

Completed buyout of German subsidiary Four 20 Pharma

Filed applications for DEA registration

, /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2026. All financial information is reported in accordance with U.S. generally accepted accounting principles ("U.S. GAAP" or "GAAP") and is provided in U.S. dollars unless otherwise indicated.

"2026 is off to a strong start across the business," stated Boris Jordan, Chairman and CEO of Curaleaf. "The macro headwinds that constrained growth over the past three years are now beginning to turn into meaningful tailwinds. Moreover, the historic rescheduling of medical cannabis provides a shift in the trajectory of our business and the industry overall, for which we are well-positioned. The investments we've made in the core pillars of our "Built for Growth" strategy are translating directly into tangible performance. First quarter revenue was $324 million, with 6% year-over-year growth, exceeding both our guidance and internal expectations. Our domestic and international segments grew 2% and 35%, respectively. Gross margin was 49% and adjusted EBITDA was $63 million, or a 20% margin, including a 170 basis point drag from international. Net income from continuing operations was $70 million or $0.09 per share. As we continue with our "Built for Growth" strategy, we believe we are uniquely positioned not just to benefit from the recent regulatory shift, but to lead the next phase of industry growth."

First Quarter 2026 Financial Highlights

Net revenue of $324.2 million, a year-over-year increase of 6% compared to Q1 2025 net revenue of $306.6 million. Sequentially, net revenue decreased 3% compared to Q4 2025 net revenue of $333.1 million Gross profit of $157.3 million and gross profit margin of 49%, a decrease of 220 basis points year-over-year Net income attributable to Curaleaf Holdings, Inc. from continuing operations of $70.1 million or net income per share from continuing operations of $0.09 Adjusted EBITDA(1) of $63.4 million and adjusted EBITDA margin(1) of 19.6%, a 200 basis point decrease year-over-year Cash at quarter end totaled $106.1 million Operating and free cash flow from continuing operations were $21.3 million and $4.3 million, respectively First Quarter 2026 Operational Highlights

Deepened retail footprint in Florida to 72 with new dispensaries opening in Lauderhill and Cape Coral Opened an adult-use sales dispensary in Bangor, ME bringing the total retail locations to six in the state Expanded Ohio footprint with opening of two Curaleaf branded dispensaries, Curaleaf Findlay and Curaleaf Lorain, in partnership with RC Retail, bringing the nationwide store total to 164 dispensaries Launched the innovative Select Briq 2 vape in 12 states   Curaleaf closed on a private placement of non-dilutive senior secured notes due February 18, 2029, for aggregate gross proceeds of $500.0 million, which were used to fully repay the outstanding Senior Secured Notes – 2026

(1) 

Adjusted EBITDA, adjusted gross profit and free cash flow are non-GAAP financial measures, and adjusted EBITDA margin and adjusted gross profit margin are non-GAAP financial ratios, in each case without a standardized definition under U.S. GAAP and which may not be comparable to similar measures used by other issuers. See "Non-GAAP Financial Performance Measures" below for definitions and more information regarding Curaleaf's use of non-GAAP financial measures and non-GAAP financial ratios. See "Reconciliation of Non-GAAP financial measures" below for a reconciliation of each non-GAAP financial measure used in this press release from the most directly comparable U.S. GAAP financial measure.

Post First Quarter 2026 Operational Highlights

Launched Dark Heart, the Company's ultra-premium flower brand, across 11 states to strong consumer reception Completed the buyout of the remaining 45% equity interest in Four20 Pharma, the Company's German subsidiary, increasing its ownership interest to 100% Appointed Torsten Greif, co-founder and managing director of Four 20 Pharma, to Curaleaf's Board of Directors Filed applications to register certain medical cannabis locations with the DEA Revenues, net by Segment

($ thousands)

Three Months Ended

March 31, 2026

December 31, 2025

March 31, 2025

Domestic:

Retail revenue

$             215,223

$             221,221

$             219,644

Wholesale revenue

61,516

61,167

51,824

Management fee income

248

23

236

Total revenues, net - Domestic

$             276,987

$             282,411

$             271,704

Three Months Ended

March 31, 2026

December 31, 2025

March 31, 2025

International:

Retail revenue

$               15,886

$               15,711

$               11,058

Wholesale revenue

28,285

29,716

22,457

Management fee income

3,073

5,230

1,405

Total revenues, net - International

$               47,244

$               50,657

$               34,920

Balance Sheet and Cash Flow

As of March 31, 2026, the Company had $106.1 million of cash and $565.1 million of outstanding debt, net of unamortized debt discounts and deferred financing fees.

During the three months ended March 31, 2026, Curaleaf invested $17.0 million in capital expenditures, focused on facility upgrades, automation and selective retail expansion in strategic markets.

Shares Outstanding

The Company's weighted average shares outstanding was 775,429,231 and 744,898,937 for the first quarter of 2026 and 2025, respectively.

Curaleaf Announces Change of Auditors

Curaleaf announces that PKF O'Connor Davies will be resigning as auditor of the Company effective as of May 6, 2026. Following a competitive solicitation process, the audit committee and Board of Directors of the Company have appointed BDO USA, P.C. ("BDO USA") as the successor auditor, effective May 6, 2026, until the close of the next annual general shareholder meeting of the Company scheduled for June 22, 2026. At such meeting, shareholders of the Company will be asked to approve the appointment of BDO USA as the independent auditors of the Company for the fiscal year ending December 31, 2026.

There were no disagreements or unresolved issues between the Company and PKF O'Connor Davies on any matter of audit scope or procedures, accounting principles or policies, or financial statement disclosure. It is the Company's opinion that there have been no "reportable events" (as defined in National Instrument 51-102 – Continuous Disclosure Obligations ("NI 51-102") between the Company and PKF O'Connor Davies. In accordance with NI 51-102, a notice of change of auditor together with the required letters from the former auditor and the successor auditor will be filed on SEDAR+ under the Company's profile at www.sedarplus.ca.

Conference Call Information

The Company will host a conference call and audio webcast for investors and analysts on Tuesday, May 5, 2026 at 5:00 P.M. ET to discuss Q1 2026 earnings results. The call can be accessed by dialing 1-844-512-2926 in North America or internationally at 1-412-317-6300. The conference pin # is 6727326.

A replay of the conference call can be accessed at 1-855-669-9658 in North America or internationally at 1-412-317-0088, using the replay pin # 2189805.

A webcast of the call can be accessed on the investor relations section of the Curaleaf website at ir.curaleaf.com. The teleconference will be available for replay starting at approximately 7:00 P.M. ET on Tuesday, May 5, 2026 and will end at 11:59 P.M. ET on May 12, 2026.

Non-GAAP Financial and Performance Measures

Curaleaf reports its financial results in accordance with U.S. GAAP and also uses certain non-GAAP financial measures and ratios to evaluate performance. These measures, which include "adjusted gross profit," "adjusted gross profit margin," "adjusted EBITDA," "adjusted EBITDA margin," and "free cash flow from operations," do not have standardized definitions under U.S. GAAP and may not be comparable to similar measures used by other issuers.

Curaleaf defines these non-GAAP measures as follows:

Adjusted gross profit: gross profit net of related add-backs. Adjusted gross profit margin: adjusted gross profit divided by total revenues, net. Adjusted EBITDA: income (loss) before interest, taxes, depreciation and amortization, net of impairment losses (recoveries), share-based compensation expense and related add-backs. Adjusted EBITDA margin: adjusted EBITDA divided by total revenues, net. Free cash flow from operations: net cash provided by operating activities from continuing operations, net of purchases and disposals of property, plant and equipment for continuing operations. Management believes these measures (i) provide investors with additional insight into Curaleaf's financial strength and underlying performance, (ii) align external reporting with how management evaluates results and (iii) facilitate comparisons with other issuers. These measures should not be considered in isolation from, or as a substitute for, U.S. GAAP results nor should they be considered as indicators of Curaleaf's future performance. Reconciliations to the most directly comparable U.S. GAAP measures are provided in the accompanying tables.

Reconciliation of Non-GAAP financial measures

Adjusted gross profit from continuing operations

($ thousands)

Three Months Ended

March 31, 2026

December 31, 2025

March 31, 2025

Gross profit from continuing operations

$           157,290

$             161,795

$            155,566

Other add-backs(1)

(125)

59

233

Adjusted gross profit from continuing
operations(2)

$           157,165

$             161,854

$            155,799

Adjusted gross profit margin from
continuing operations(2)

48.5 %

48.6 %

50.8 %

(1) Other add-backs reflect the impact on cost of goods sold from non-routine severance costs and non-cash inventory adjustments.

(2) Represents a Non-GAAP measure or Non-GAAP ratio. See "Non-GAAP Financial and Performance Measures" section of this press release for definitions and more information regarding Curaleaf's use of Non-GAAP financial measures and Non-GAAP ratios. The table above provides a reconciliation of Gross profit from continuing operations, the most comparable GAAP measure, to Adjusted gross profit from continuing operations, a non-GAAP measure.

Gross profit from continuing operations was $157.3 million in the first quarter of 2026, compared with $155.6 million in the prior-year period. On an adjusted basis, gross profit from continuing operations was $157.2 million compared with $155.8 million in the prior-year period, and adjusted gross profit margin from continuing operations was 48.5%, compared with 50.8% in the prior-year period, a decrease of 230 basis points.

Adjusted EBITDA

($ thousands)

Three Months Ended

March 31, 2026

December 31, 2025

March 31, 2025

Net income (loss)

$              69,783

$            (57,617)

$            (60,246)

Net loss from discontinued operations

(293)

(8,276)

(10,193)

Net income (loss) from continuing operations

70,076

(49,341)

(50,053)

Interest expense, net

25,315

24,324

25,074

(Benefit) provision for income taxes

(98,705)

25,215

33,653

Depreciation and amortization(1)

47,855

49,622

48,829

Share-based compensation

9,664

12,341

4,624

Loss on impairment



5,745

3,695

Total other expense (income), net

4,067

(3,026)

(3,003)

Other add-backs(2)

5,141

4,122

3,275

Adjusted EBITDA(3)

$              63,413

$              69,002

$              66,094

Adjusted EBITDA Margin(3)

19.6 %

20.7 %

21.6 %

(1) Depreciation and amortization includes amounts charged to Cost of goods sold on the Statement of Operations of $14.2 million, $14.2 million, and $13.4 million for the three months ended March 31, 2026, December 31, 2025 and March 31, 2025, respectively.

(2) Other add-backs primarily consisted of costs related to restructuring, legal fees, and lobbying costs.

(3) Represents a Non-GAAP measure or Non-GAAP ratio. See "Non-GAAP Financial and Performance Measures" section of this press release for definitions and more information regarding Curaleaf's use of Non-GAAP financial measures and Non-GAAP ratios. The table above provides a reconciliation of Net loss, the most comparable GAAP measure, to Adjusted EBITDA, a non-GAAP measure.

Adjusted EBITDA was $63.4 million for the first quarter of 2026, compared to $66.1 million for the first quarter of 2025, and Adjusted EBITDA margin decreased to 19.6%.

Free cash flow

($ thousands)

Three months ended

March 31, 2026

Net cash provided by operating activities from continuing operations

$                 21,271

Less: Purchases of property, plant and equipment, net of disposals

(16,985)

Free cash flow from continuing operations(1)

$                  4,286

(1) Represents a Non-GAAP measure or Non-GAAP ratio. See "Non-GAAP Financial and Performance Measures" section of this press release for definitions and more information regarding Curaleaf's use of Non-GAAP financial measures and Non-GAAP ratios. The table above provides a reconciliation of Net cash provided by operating activities from continuing operations, a GAAP measure, to Free cash flow from continuing operations, a non-GAAP measure.

Condensed Interim Consolidated Balance Sheets (Unaudited)

($ thousands)

As of

March 31, 2026

December 31, 2025

Assets

Cash and cash equivalents (including restricted cash and cash
equivalents)

$              106,129

$              101,573

Other current assets

355,387

347,050

Property, plant and equipment, net

509,153

520,386

Right-of-use assets, finance lease, net

91,646

97,599

Right-of-use assets, operating lease, net

112,147

113,274

Intangible assets, net

982,061

1,011,115

Goodwill

633,524

635,117

Other non-current assets

21,531

19,201

Total assets

$            2,811,578

$            2,845,315

Liabilities, Temporary equity and Shareholders' equity

Total current liabilities

$              296,342

$              294,314

Total non-current liabilities

1,606,127

1,710,720

Redeemable non-controlling interest contingency

87,997

83,931

Total shareholders' equity

821,112

756,350

Total liabilities, temporary equity and shareholders' equity

$            2,811,578

$            2,845,315

Condensed Interim Consolidated Statements of Operations (Unaudited)

($ thousands, except for share and per share amounts)

Three months ended
March 31,

2026

2025

Revenues, net:

Retail and wholesale revenues

$   320,910

$   304,983

Management fee income

3,321

1,641

Total revenues, net

324,231

306,624

Cost of goods sold

166,941

151,058

Gross profit

157,290

155,566

Operating expenses:

Selling, general and administrative

113,206

106,194

Share-based compensation

9,664

4,624

Depreciation and amortization

33,667

35,382

Total operating expenses

156,537

146,200

Income from continuing operations

753

9,366

Other income (expense):

Interest income

212

171

Interest expense related to notes payable and deferred consideration liabilities

(15,024)

(14,161)

Interest expense related to lease liabilities and financial obligations

(10,503)

(11,084)

Loss on impairment



(3,695)

Other (expense) income, net

(4,067)

3,003

Total other expense, net

(29,382)

(25,766)

Loss before benefit (provision) for income taxes

(28,629)

(16,400)

Benefit (provision) for income taxes

98,705

(33,653)

Net income (loss) from continuing operations

70,076

(50,053)

Net loss from discontinued operations

(293)

(10,193)

Net income (loss)

69,783

(60,246)

Less: Net (loss) income attributable to non-controlling interest

(16)

817

Net income (loss) attributable to Curaleaf Holdings, Inc.

$     69,799

$    (61,063)

Per share – basic and diluted:

Net income (loss) per share from continuing operations

$        0.09

$       (0.09)

Weighted average common shares outstanding

775,429,231

744,898,937

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading global provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Anthem, Curaleaf, Dark Heart, Find, Four20 Pharma, Grassroots, Green Britannia, Huala, JAMS, Reef and Select, provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Curaleaf IR X Account: https://x.com/Curaleaf_IR 

Investor Relations Website: https://ir.curaleaf.com/

Contact Information:

Investor Contact: 
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
[email protected]

Media Contact: 
MATTIO Communications
[email protected]

Disclaimer

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of Canadian and U.S. securities laws (together, "forward-looking statements"). Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on management's current beliefs, expectations or assumptions regarding the future of the Company's business, future plans and strategies, operational results and other future conditions. In addition, management may make or approve certain statements, in future filings with applicable Canadian regulatory authorities and/or the SEC, in press releases or in presentations by representatives of the Company that are not statements of historical fact and which may also constitute forward-looking statements. All statements, other than statements of historical fact, made by management that address activities, events or developments that management expects or anticipates will or may occur in the future are forward-looking statements, including, but not limited to, statements preceded by, "followed by" or that include words such as "may", "will", "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "intends", "anticipates", "targeted", "continues", "forecasts", "designed", "goal" or the negative of those words or other similar or comparable words and includes, among others, information regarding: expectations of the effects and potential benefits of any transactions; statements relating to the Company's business, future activities and developments after the date of this press release, including such things as future business strategy, competitive strengths, goals, expansion and growth. Forward-looking statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments. These statements speak only as of and at the date they are made and are based on information currently available and current expectations at that time.

Holders of the Company's securities are cautioned that forward-looking statements are not based on historical facts, but instead are based on reasonable assumptions and management's estimates at the time they were provided or made and involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements, including, but not limited to, risks and uncertainties relating to: the legality of cannabis in the U.S., including its classification as a controlled substance under the U.S. Federal Controlled Substances Act (the "CSA"); compliance with anti-money laundering laws and regulations; the lack of access to U.S. bankruptcy protections; financing constraints, including limited access to banking and risks associated with raising additional capital; general regulatory and legal restrictions, including limitations imposed by the TSX; potential legal, regulatory or political changes; licensing and ownership limitations; regulatory actions and approvals from the U.S. Food and Drug Administration ("FDA"), including the risk of increased FDA oversight; potential heightened scrutiny by regulators; loss of foreign private issuer status; internal control deficiencies; litigation exposure; higher compliance costs as a public company in both Canada and the U.S.; recent and proposed U.S. cannabis and hemp licensing legislation; environmental risks, including compliance with environmental regulations and unforeseen environmental liabilities; expansion into foreign jurisdictions; future acquisitions or dispositions; dependence on key suppliers and service providers; enforceability of contracts; risks associated with the Company's SVS, including resale limitations, limited liquidity for U.S. investors, market price volatility as well as significant sales of SVS; reliance on senior management and other key personnel, including challenges in recruiting and retaining such personnel; competitive pressures; risks inherent in agricultural operations; adverse publicity or shifts in consumer perception; product liability and recalls; uncertainty regarding results of future clinical research; reliance on agricultural inputs; limited market data and forecasting uncertainty, including the risk that past performance or financial projections may not be reliable indicators of future results; intellectual property risks; marketing and advertising restrictions; fraudulent or illegal activity by employees, consultants or contractors; labor risks, including potential union activity; information technology failures, cyber-attacks or security breaches; reliance on management services agreements with subsidiaries and affiliates; website accessibility and digital compliance requirements; high bonding and insurance costs; risks associated with leverage and debt management; challenges related to growth and scalability; conflicts of interest; global economic pressures, including tariffs, retaliatory measures and trade disputes; currency exchange fluctuations; risks related to the Company's business structure and securities, including the Company's status as a holding company, lack of dividend history, indebtedness and concentrated voting control; limited shareholder rights in corporate affairs; enforcement challenges against directors and officers residing outside Canada; tax risks and those risks described under the heading "Risk Factors" in the Annual Information Form dated February 26, 2026 for the fiscal year ended December 31, 2025, whch has been filed on the Company's SEDAR+ profile at www.sedarplus.ca and on its EDGAR profile at www.sec.gov/edgar/html), and as described from time to time in documents filed by the Company with Canadian securities regulatory authorities.

The purpose of forward-looking statements is to provide the reader with a description of management's  expectations, and such forward-looking statements may not be appropriate for any other purpose. Although management believes that the expectations reflected in such forward-looking statements are reasonable, management can give no assurance that such expectations will prove to be correct. A number of factors could cause actual events, performance or results to differ materially from what is projected in the forward-looking statements, and undue reliance should not be placed on forward-looking statements contained in this press release. Such forward-looking statements are made as of the date of this press release. Management undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Management's forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither the Toronto Stock Exchange nor its Regulation Service Provider has reviewed and does not accept responsibility for the adequacy or accuracy of the content of this press release.

SOURCE Curaleaf Holdings, Inc.
2026-06-12 17:49 3mo ago
2026-05-05 19:05 4mo ago
Curaleaf Holdings, Inc. (CURLF) Q1 Earnings and Revenues Top Estimates
CURLF Curaleaf Holdings
FMP Stock News
Original source text
Curaleaf Holdings, Inc. (CURLF) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to a loss of $0.07 per share a year ago.
2026-06-12 17:49 3mo ago
2026-05-05 22:01 4mo ago
Curaleaf Holdings, Inc. (CURA:CA) Q1 2026 Earnings Call Transcript
CURLF Curaleaf Holdings
FMP Stock News
Original source text
Curaleaf Holdings, Inc. (CURA:CA) Q1 2026 Earnings Call Transcript
2026-06-12 17:49 3mo ago
2026-05-08 07:45 4mo ago
Curaleaf Bolsters Florida Footprint with Two New Medical Dispensaries in Jacksonville Beach and Fernandina Beach
CURLF Curaleaf Holdings
FMP Stock News
Original source text
Latest openings increase the Company's Florida medical dispensary count to 73, with 165 locations nationwide

, /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of two new medical dispensaries in Florida, one in Jacksonville Beach and the other in Fernandina Beach. The two new locations bring the Company's Florida footprint to 73 dispensaries and its nationwide total to 165 stores.

Located at 13799 Beach Boulevard, Curaleaf Jacksonville Beach sits along U.S. Route 90, one of the area's primary east-west corridors connecting the city's core to its coastal communities, and is surrounded by a diverse mix of restaurants, hotels, and retail shops. Curaleaf Fernandina Beach is located at 1951 South 8th Street along Florida State Road 200, offering convenient access to surrounding neighborhoods and nearby coastal destinations with a variety of local retail, dining, and businesses. Each dispensary offers a broad range of products and brands for medical patients, featuring Curaleaf's Florida-exclusive Reef flower, Grassroots flower, Dark Heart flower, Anthem pre-rolls, and the new Select Briq 2, designed to deliver enhanced flavor and real-time dose visibility.

"Our two newest dispensaries in Northeast Florida mark our fourth and fifth openings in the state since the beginning of the year," said Boris Jordan, Chairman and CEO of Curaleaf. "The continued expansion of our Florida retail footprint reflects our long-term strategy to strengthen our presence in this key medical cannabis market. As we continue to scale thoughtfully across Florida, we're enhancing our ability to deliver localized product offerings and patient-focused services while maintaining consistent, high-quality access for the medical community statewide."

A grand opening celebration will take place at Curaleaf Jacksonville Beach on Friday, May 8 and Saturday, May 9, from 12:00 - 8:00 P.M. ET. The event will feature live music, live art, and a variety of in-store promotions, along with the launch of monthly spend-to-win contests through the summer. On Friday, May 15 and Saturday, May 16, Curaleaf Fernandina Beach will also host a two-day grand opening event from 12:00 - 8:00 P.M. ET, with branded merch and giveaways. Items you could win include a $250 store credit, a tour of the cultivation facility located in Mount Dora, a beach bundle, stand up paddle board, and a signed football jersey. On the grand opening Friday, May 8, the first 50 patients at Curaleaf Jacksonville Beach will receive a complimentary eighth with any $75 purchase, subject to select strains. On Friday, May 15, the same offer will be available at Curaleaf Fernandina Beach for the first 50 patients. Both locations will operate from 9:00 A.M. to 8:30 P.M. Monday through Saturday, and 10:00 A.M. to 7:00 P.M. ET on Sunday.

For more information on Curaleaf's Florida dispensaries, products, and patient resources, please visit https://curaleaf.com/dispensary/florida.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of dispensaries in Jacksonville Beach and Fernandina Beach, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on May 5, 2026, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
[email protected] 

Media Contact:
MATTIO Communications
[email protected]

SOURCE Curaleaf Holdings, Inc.
2026-06-12 17:49 3mo ago
2026-05-26 07:45 3mo ago
Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Stock Exchange Uplisting
CURLF Curaleaf Holdings
FMP Stock News
Original source text
In consultation with U.S. stock exchanges, Reverse Stock Split prepares Curaleaf for uplisting, in response to U.S. cannabis rescheduling STAMFORD, Conn., May 26, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that a 1-for-3 reverse stock split of its shares will become effective on or about June 5, 2026 (the "Reverse Stock Split").
2026-06-12 17:49 3mo ago
2026-06-01 10:32 3mo ago
Cannabis Stocks Are Heating Up Again. Here's Which Ones Could be the Biggest Winners.
CURLF Curaleaf Holdings
FMP Stock News
Original source text
The post-280E era will usher in new winners among cannabis stocks.
2026-06-12 17:49 3mo ago
2026-06-02 10:00 3mo ago
Best Marijuana Stocks to Watch for Potential Upside in June 2026
CURLF Curaleaf Holdings
FMP Stock News
Original source text
As June 2026 begins, cannabis investors continue searching for companies with strong operations and improving profitability. Although the industry still faces regulatory challenges, many leading operators have strengthened their balance sheets. Additionally, several companies continue generating significant revenue despite difficult market conditions.